Cinnamon & Type 2 Diabetes: Evidence, Dosing & Safety
Evidence Summary
- Glycemic control: Meta-analyses (10–15 RCTs) show cinnamon 1–6 g/day reduces fasting glucose 10–25 mg/dL and HbA1c 0.3–0.5% vs. placebo in T2D.
- Insulin sensitivity: Improves HOMA-IR in some trials; polyphenols (MHCP) enhance insulin signaling.
- Lipids: Modest reductions in total cholesterol, LDL-C, triglycerides.
- Antioxidant/anti-inflammatory: Cinnamaldehyde, polyphenols scavenge ROS, inhibit NF-κB.
Cinnamon Types Matter
- Ceylon (C. verum): Low coumarin (<0.004%); preferred for daily use.
- Cassia (C. cassia): High coumarin (1–5%); hepatotoxic risk at >1 tsp/day long-term.
Practical Recommendations
- Dose: 1–3 g/day (½–1 tsp) Ceylon cinnamon powder in food/beverage.
- Duration: Trial 3–6 months; monitor HbA1c, LFTs.
- Form: Powder > capsules (quality control); avoid essential oil internally.
- Contraindications: Liver disease, anticoagulants (potentiation), pregnancy (high dose).
Bottom Line
Cinnamon is a promising adjunct, not a replacement for guideline-directed therapy. Discuss with your diabetes team before starting.
Diabetes - Related Articles
- Diabetic Skin Problems: Causes, Symptoms & Management
- Culturally Competent Type 2 Diabetes Care for Hispanic/Latino Communities
- Understanding A1C: Diabetes Blood Sugar Control
- Understanding Post-Meal Blood Sugar: Causes & Normal Ranges
- Understanding Diabetic Syringes: Types, History & Choosing the Right One
- Calculating Basal Rates for Insulin Pumps: A Step-by-Step Guide
- Type 2 Diabetes & Life Expectancy: Understanding the Risks
